NDC 0069-0249 – Ruxience
Rituximab 500 mg/50mL · Injection, Solution · Intravenous
Product NDC0069-0249
Product details
- Brand name
- Ruxience
- Generic name
- Rituximab-pvvr
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761103
- Marketed since
- January 23, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD20-directed Cytolytic Antibody
Active ingredients
- Rituximab 500 mg/50mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0249-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0069-0249-01) / 50 mL in 1 VIAL, SINGLE-USE | Jan 23, 2020 |
Other Ruxience products
- 0069-0238 Rituximab 100 mg/10mL · Injection, Solution · Pfizer Laboratories Div Pfizer Inc